{1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution) / 1... — RxCUI 2685490
RxNorm drug concept · Generic pack
RxCUI 2685490
Generic pack · GPCK
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2685490
Official name{1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution) / 1 (diphenhydramine hydrochloride 0.833 MG/ML Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 daytime (dextromethorphan HBr 10 MG / guaifenesin 200 MG per 15 mL Oral Solution) / 1 nighttime (diphenhydramine hydrochloride 12.5 MG per 15 mL Oral Solution) Pack; 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG in 15 mL Oral Solution) / 1 nighttime (diphenhydrAMINE hydrochloride 12.5 MG in 15 mL Oral Solution) Pack
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You can use it for temporary relief of pain and itching from everyday skin problems — things like insect bites, minor burns, minor cuts and scrapes, and general skin irritations. I...
- What can I actually use this cream or spray for?
- You can apply it up to 3 to 4 times a day, but no more than that. More frequent use isn't going to help more — and the label is clear that you shouldn't exceed that limit. For kids...
- This is really important — do not use this topical product at the same time as any other product that contains diphenhydramine, even a pill or capsule. That includes allergy medici...
🕸️ Concept Web — How {1 (dextromethorphan hydrobromide 0.667 MG/ML /... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
{1 (dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution) / 1 (diphenhydramine hydrochloride 0.833 MG/ML Oral Solution) } Pack
RxCUI 2685490 Generic pack · GPCK
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Diphenhydramine
3498IN -
Guaifenesin
5032IN -
Dextromethorphan / guaifenesin
214488MIN -
Dextromethorphan hydrobromide
102490PIN -
Diphenhydramine hydrochloride
1362PIN
-
Dextromethorphan
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan / guaifenesin Oral Solution
371766SCDF -
Diphenhydramine Oral Solution
371889SCDF -
Dextromethorphan hydrobromide / guaifenesin Oral Solution
2647597SCDFP -
Diphenhydramine hydrochloride Oral Solution
2647041SCDFP -
Dextromethorphan / guaifenesin Oral Liquid Product
1155190SCDG -
Dextromethorphan / guaifenesin Oral Product
1155191SCDG -
Diphenhydramine Oral Liquid Product
1158448SCDG -
Diphenhydramine Oral Product
1158449SCDG - +7 more in this family
-
Dextromethorphan / guaifenesin Oral Solution
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution
1014005SCD -
Diphenhydramine hydrochloride 0.833 MG/ML Oral Solution
2685488SCD -
Dextromethorphan hydrobromide 0.667 MG/ML
1014004SCDC -
Diphenhydramine hydrochloride 0.833 MG/ML
1294606SCDC -
Guaifenesin 13.3 MG/ML
331390SCDC
-
Dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution
Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 13.3 MG/ML Oral Solution
SCD · 1014005 -
Diphenhydramine hydrochloride 0.833 MG/ML Oral Solution
SCD · 2685488 -
Dextromethorphan hydrobromide 0.667 MG/ML
SCDC · 1014004 -
Diphenhydramine hydrochloride 0.833 MG/ML
SCDC · 1294606 -
Guaifenesin 13.3 MG/ML
SCDC · 331390 -
Dextromethorphan / guaifenesin Oral Solution
SCDF · 371766 -
Diphenhydramine Oral Solution
SCDF · 371889 -
Dextromethorphan hydrobromide / guaifenesin Oral Solution
SCDFP · 2647597 -
Diphenhydramine hydrochloride Oral Solution
SCDFP · 2647041 -
Dextromethorphan / guaifenesin Oral Liquid Product
SCDG · 1155190
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2685490 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 84126-0312-12 | 1 KIT in 1 PACKAGE (84126-312-12) * 177 mL in 1 BOTTLE, PL... | Vicks DayQuil Kids and Vicks NyQuil Kids FREE OF ARTIFICIAL DYES and SUGAR COLD and COUGH plus | The Procter & Gamble Manufacturing Company | 2024-06-25 |
Observed labelers:
The Procter & Gamble Manufacturing Company (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.